MilliporeSigma develops System Service Reliance Plans

Published: 8-Nov-2021
Regulatory

The data sheet is available to download for free now

To ensure optimum equipment uptime and regulatory compliance while mitigating risks, we have developed System Service Reliance Plans; a complete range of services for your systems and equipment. These comprehensive service and support packages allow you to select a coverage level that best fits your needs. The Essential Reliance Plan includes a selection of preventive maintenance and troubleshooting services while the Advanced Reliance Plan provides higher coverage, with faster response time and priority access to remote and on-site support.

All services are performed by our global experts who have intimate knowledge of our equipment, backed by decades of experience.

Download MilliporeSigma's data sheet.

  • Companies:
  • Merck Electronics KGaA
See more

You may also like

Regulatory

Merck announces collaboration with Agilent to fill PAT gap for downstream processing

Read more
Collaboration will help to enable real-time release and Bioprocessing 4.0

Trending Articles

  1. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  5. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

Merck announces collaboration with Agilent to fill PAT gap for downstream processing

Collaboration will help to enable real-time release and Bioprocessing 4.0
Regulatory

Merck licenses foundational CRISPR technology to Cellecta

Cellecta provides RNAi and CRISPR technologies for the discovery and characterisation of novel therapeutic targets and genetic profiling for drug and biomarker discovery and validation
Regulatory

4D pharma, Merck and Pfizer trial combination carcinoma treatment

MRx0518 is currently being evaluated in three clinical trials in patients with cancer
Manufacturing

Big names announced for leading Pharma and Cleanroom conference

The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Ingredients

Therapeutics: tepotinib for lung cancer

Lung cancer is the most common type of cancer, with an estimated 2 million cases being diagnosed every year and 1.7 million deaths recorded
Packaging

The pharmaceutical supply chain: Are we ready for change?

A tremendous change agent, serialisation data has the power to drive a safer, more efficient pharmaceutical supply chain — for everyone, reports John Bermudez, General Manager, Digital Network Platform, TraceLink
Ingredients

Therapeutics: evobritinib for multiple sclerosis

There is a growing body of evidence suggesting that, as well as regulating normal autoimmunity, B-cells are also involved in immune-mediated diseases, including multiple sclerosis (MS)
Subscribe now